MedTrace Logo

Circulating Fetal Cells and Breast Cancer

NCT04903990 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-06-16

No results posted yet for this study

Summary

After pregnancy, fetal cells remain in a woman's body for years. These cells may be involved in different physiological situations (e.g. wound healing) and diseases (e.g. cancer).The study will evaluate the level of circulating fetal immune cells in patients with breast cancer vs controls with benign breast tumors, and further characterize these fetal cells. Patients participation will be limited to accepting that an additional blood sample is collected on the day of their preop consultation and blood test.

Conditions

Interventions

OTHER

Blood sample

As part of the treatment, 2 EDTA tubes of 10mL will be taken during a scheduled venipuncture as part of the preoperative assessment.

Sponsors & Collaborators

  • Ruban Rose

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Nathalie CHABBERT-BUFFET, PUPH · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-14
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04903990 on ClinicalTrials.gov